Craig A. Erickson, MD
- 4Articles
- 14KReads
- 2005–2014Active
- 10Collaborators
- 24Citations
About
Craig A. Erickson, MD, has published extensively on neurodevelopmental disorders, with a focus on autism spectrum disorder and related conditions. His work includes studies on pharmacological treatments such as intranasal ketamine, atypical antipsychotics, and memantine for behavioral symptoms in autism. Erickson has also contributed to research on the neurochemistry underlying autism and has addressed topics related to neurology, schizophrenia, schizoaffective disorders, and suicide. His publications appeared from 2005 to 2014 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
